Supreme Court questions how far generics makers can go with 'skinny label' drugs

WASHINGTON — Supreme Court justices gave a few hints about how they intend to rule in a divisive case for the pharmaceutical industry. In its final argument scheduled for this term, the high court on Wednesday ...